Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-864-4 | CAS number: 2921-88-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5375 - In vitro Mammalian Chromosome Aberration Test
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.10 (Mutagenicity - In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: Japanese Ministry of Agriculture, Forestry and Fisheries, 12-Nousan-8147, Chromosomal Aberration Studies, 2-1-19-2
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Chlorpyrifos
- EC Number:
- 220-864-4
- EC Name:
- Chlorpyrifos
- Cas Number:
- 2921-88-2
- Molecular formula:
- C9H11Cl3NO3PS
- IUPAC Name:
- O,O-diethyl O-3,5,6-trichloropyridin-2-yl phosphorothioate
- Test material form:
- solid
Constituent 1
- Specific details on test material used for the study:
- Substance ID: TSN308540
Lot Number: 2K04161692
Purity: 98.0 wt%
Method
Species / strain
- Species / strain / cell type:
- lymphocytes: human peripheral blood
- Details on mammalian cell type (if applicable):
- CELLS USED
- Sex, age and number of blood donors if applicable: healthy, 33 year old male volunteer
- Whether whole blood or separated lymphocytes were used if applicable: Whole blood
MEDIA USED
The whole blood was cultured in RPMI-1640 (Roswell Park Memorial Institute) with L-glutamine and 25 mm HEPES (Sigma R4130) containing penicillin and streptomycin supplemented with 20% heat-inactivated (56 °C; 30 min) fetal bovine serum.
- Metabolic activation:
- with and without
- Metabolic activation system:
- rat liver (treated with Aroclor 1254) S9 fraction
- Test concentrations with justification for top dose:
- Cytotoxicity test: 20.48, 51.2, 128, 320, 800 and 2000 μg/mL
Main study: 25, 50, 100, 150, 200 and 250 μg/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Dimethyl sulfoxide (DMSO)
- Justification for choice of solvent/vehicle: As per the guideline’s requirement for highest test concentration, solubility was tested at 200000 μg/mL (100X stock in DMSO). Test item was insoluble in sterile distilled water, while found completely soluble in dimethyl sulfoxide.
Controls
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- mitomycin C
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: In medium
SPINDLE INHIBITOR: Colchicine
STAIN: 5% Giemsa in phosphate buffer
METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: Slides were prepared from each culture tube by dropping approximately about 0.5 mL of the fixed cell suspension, drop by drop on two, pre-cleaned, ice-chilled slides. The slides were dried over a slide warmer and labeled with study number, culture number and slide number. The dried slides were stained with 5% Giemsa in phosphate buffer for 8 minutes. The slides were made permanent by mounting a cover slip with DPX mountant. Out of these two slides, one was used for scoring and the other served as reserve.
NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE: 150 metaphases per replicate
DETERMINATION OF CYTOTOXICITY
- Method: Mitotic index
OTHER EXAMINATIONS:
Only cells containing 46 ± 2 chromosomes were examined for structural changes. A smaller number (e.g. 50 metaphases per slide) of metaphases were analysed in slides showing higher frequency (more than 20%) of aberrant cells. Gaps, breaks, fragments, exchanges, deletions, rings and other aberrations were recorded with their numbers and frequencies for all the treated and control cultures separately. In addition, 100 metaphases/replicate were examined for polyploidy. The number of metaphases with only gap, endoreduplication or polyploidy were recorded but not considered to calculate total aberrations and percent aberrant cells. - Evaluation criteria:
- The test substance was considered to have shown clastogenic activity in this study if the following criteria were met: Increased frequency of metaphases with aberrant chromosomes observed at one or more test concentrations (concentration-related); Increases were reproducible between replicate cultures and between tests (when treatment conditions are the same); Increases in percent aberrant metaphases were statistically significant; Increases in percent aberrant metaphases were not associated with large changes in pH and osmolality of the treatment medium.
Historical control data was also considered in the evaluation.
An increase in the number of polyploid cells indicates that the test substance has the potential to inhibit mitotic processes and to induce numerical chromosome aberration. Biological relevance was considered first. The test substance was considered non-mutagenic if the results did not meet the above mentioned criteria. - Statistics:
- Gaps and polyploidy were not included in the calculation of total aberration frequency. Data on mitotic index, polyploidy and percent aberrant cells were subjected to Bartlett’s test to meet the homogeneity of variance before conducting Analysis of Variance (ANOVA) and Dunnett’s t-test (Gad. and Weil, 1994). Where the data did not meet the homogeneity of variance, Student's t-test was performed to determine the level of significant difference between the negative control and three selected test concentrations (selected based on the mitotic index data) and positive controls.
Reference: Gad, S.C. and Weil, C.S. (1994). Statistics for Toxicologists. In: Principles and Methods of Toxicology, Third Edition, Hayes A.W. (Ed.). Raven Press Ltd., New York, pp. 221-274.
Results and discussion
Test results
- Key result
- Species / strain:
- lymphocytes: Human peripheral blood
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- Significant level of cytotoxicity, i.e. >50% reduction in the mitotic index, was observed at test concentrations of 320 μg/mL both in the absence and presence of metabolic activation system
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH and osmolality: A significant change in pH (±1 unit) or osmolality (≥50 mOsm/kg H2O) was not observed at 0 and 4 h in any of the tested concentrations of 62.5, 125, 250, 500, 1000 and 2000 μg/mL of culture medium.
- Water solubility: Test substance was insoluble in sterile distilled water
- Precipitation: Precipitation was not observed at the tested concentrations of 62.5, 125, 250, 500 and 1000 of culture medium, while slight precipitation was observed at 2000 μg/mL of culture medium.
RANGE-FINDING/SCREENING STUDIES: The cytotoxicity was assessed based on the results of precipitation, pH and osmolality tests at the concentrations of 20.48, 51.2, 128, 320, 800 and 2000 μg/mL of culture medium. The reduction in mitotic index observed was -3.92, -1.74, -2.87, 77.91, 87.34, 98.43 % and -11.59, -2.79, 1.72, 73.79, 91.86 and 100 % at the concentrations of 20.48, 51.2, 128, 320, 800 and 2000 μg/mL of test substance, in the absence and presence of metabolic activation (2% v/v S9), respectively.
Therefore, significant level of cytotoxicity, i.e. >50% reduction in the mitotic index, was observed at test concentrations of 320 μg/mL both in the absence and presence of metabolic activation system. Hence, 250 μg/mL was selected as the highest test concentration to be tested in the main study.
Any other information on results incl. tables
Table 1: Summary of Percent Mitotic index, Percent Aberrant and Polyploid Cells
Concentration of test substance |
Phase I [Absence of Metabolic Activation] |
||
% Mitotic Index |
% Aberrant Cells |
% Polyploid Cells |
|
Mean ± SD |
Mean ± SD |
Mean ± SD |
|
NC (DMSO) |
5.484 ± 0.282 |
2.665 ± 0.940 |
0.500 ± 0.707 |
100 μg/mL |
5.172 ± 1.013 |
2.000 ± 0.948 |
0.000 ± 0.000 |
150 μg/mL |
4.553 ± 0.682 |
2.335 ± 0.474 |
0.000 ± 0.000 |
200 μg/mL |
2.787 ± 0.289↓ |
1.665 ± 0.474 |
0.500 ± 0.707 |
PC |
3.282 ± 0.415↓ |
24.000 ± 2.828↑↑ |
0.000 ± 0.000 |
Concentration of test substance |
Phase I [Presence of Metabolic Activation (1% v/v S9)] |
||
% Mitotic Index |
% Aberrant Cells |
% Polyploid Cells |
|
Mean ± SD |
Mean ± SD |
Mean ± SD |
|
NC (DMSO) |
4.672 ± 0.279 |
2.000 ± 0.948 |
0.000 ± 0.000 |
100 μg/mL |
4.172 ± 0.547 |
2.000 ± 0.948 |
0.000 ± 0.000 |
150 μg/mL |
3.684 ± 0.371 |
2.335 ± 0.474 |
0.000 ± 0.000 |
200 μg/mL |
2.395 ± 0.569↓ |
2.000 ± 0.948 |
0.000 ± 0.000 |
PC |
2.876 ± 0.441↓ |
24.000 ± 2.828↑↑ |
0.000 ± 0.000 |
Concentration of test substance |
Phase II [Absence of Metabolic Activation |
||
% Mitotic Index |
% Aberrant Cells |
% Polyploid Cells |
|
Mean ± SD |
Mean ± SD |
Mean ± SD |
|
NC (DMSO) |
4.714 ± 0.688 |
2.335 ± 0.474 |
0.500 ± 0.707 |
25 μg/mL |
4.315 ± 0.244 |
1.665 ± 0.474 |
0.500 ± 0.707 |
50 μg/mL |
3.824 ± 0.332 |
2.335 ± 0.474 |
0.000 ± 0.000 |
100 μg/mL |
2.476 ± 0.157↓ |
1.665 ± 0.474 |
0.000 ± 0.000 |
PC |
2.836 ± 1.061 |
23.000 ± 1.414↑↑ |
0.000 ± 0.000 |
NC = Negative control, SD = Standard deviation, PC = Positive control (Mitomycin-C @ 0.3 μg/mL in the absence of S9 and Cyclophosphamide @ 40 μg/mL in the presence of S9), DMSO = Dimethyl sulfoxide
↑↑ = Significantly higher than the control at 1% level (p≤0.01)
↓ = Significantly lower than the control at 5% level (p≤0.05)
Applicant's summary and conclusion
- Conclusions:
- No potential to induce chromosomal aberrations in Human peripheral blood lymphocyte cultures; negative for clastogenicity
- Executive summary:
In a mammalian chromosome aberration test, human peripheral blood lymphocytes cultured in vitro were exposed to the test substance at different concentrations both in the absence and presence of metabolic activation (1% v/v S9). The study was conducted following OECD guideline 473 and EPA OCSPP 870.5375.
The test substance was tested in two independent experiments, in the absence and presence of metabolic activation (1% v/v S9). Human peripheral blood lymphocyte cultures were exposed to the test substance at 6 dose-levels (two cultures/dose level) between 25 and 250 μg/mL of culture medium in main study experiment, selected from a preliminary cytotoxicity test.
The test substance did not induce statistically significant or biologically relevant increases in the number of cells with chromosome aberrations in the absence and presence of S9-mix in either of the two independently conducted experiments. No effects of test substance on the number of polyploid cells or number of cells with endoreduplicated chromosomes were observed either in the absence or presence of S9-mix. All negative controls were within the historical limits and positive controls showed an increase in the incidence of cells with chromosome aberrations.
All criteria for a valid study were met as described in the protocol. From the results of this study, it is concluded that the test substance did not show potential to induce chromosomal aberrations both in the absence and presence of metabolic activation system under the described experimental conditions and is negative for clastogenicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.